Skip to content

Clinical trials

Completed Phase 2/3 Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 2/3 Status: Completed Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
20051
20062
20081
20111
20131
20141
20171
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eyetech Pharmaceuticals3
Alkeus Pharmaceuticals, Inc.1
Johns Hopkins University1
King's College Hospital NHS Trust1
Medical University of Vienna1
Pacific Eye Associates1
Paul Yates, MD, PhD1
Rudolf Foundation Clinic1
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration13
Wet Macular Degeneration3
Choroidal Neovascularization2
Geographic Atrophy2
Glaucoma1
Retinal Detachment1
Retinal Hemorrhage1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.